Bladder metastasis from epidermal growth factor receptor mutant lung cancer: A case report

被引:0
|
作者
Cai-Bao Jin [1 ]
Ling Yang [1 ]
机构
[1] Department of Thoracic Oncology, Hubei Cancer Hospital
关键词
D O I
暂无
中图分类号
R734.2 [肺肿瘤];
学科分类号
100214 ;
摘要
BACKGROUND Bladder metastasis from lung cancer with epidermal growth factor receptor(EGFR) mutation is extremely rare. Here, we report a case of bladder metastasis from lung adenocarcinoma with EGFR mutation.CASE SUMMARY A 53-year-old female patient was diagnosed with advanced lung adenocarcinoma with EGFR exon 19 deletion. Multiple nodules on the bladder wall were found by regular examination of the pelvic cavity through computed tomography during targeted therapy. Further cystoscopy and histological examination of bladder biopsy tissues confirmed the bladder metastasis from lung adenocarcinoma. In addition, genetic analysis of the bladder metastasis revealed EGFR T790M mutation. The patient achieved a good response to a third-generation EGFR tyrosine kinase inhibitor.CONCLUSION During routine follow-up of lung cancer patients, imaging examination of the pelvic cavity should be performed to avoid missing bladder metastasis. The ultimate diagnosis of bladder metastasis sill depends on the pathological result of biopsy tissues.
引用
收藏
页码:3356 / 3361
页数:6
相关论文
共 50 条
  • [22] Development Of Lung Adenocarcinoma With Epidermal Growth Factor Receptor Mutation In Patients With Breast Cancer History: Case Report
    Fernandez, L.
    Vargas, D. A.
    Sua, L. F.
    Gomez, L. I.
    Rodriguez, L. X.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [23] Small-cell lung cancer with epidermal growth factor receptor mutation: Case report and review of literature
    Asai, N.
    Ohkuni, Y.
    Matsuda, M.
    Kaneko, N.
    INDIAN JOURNAL OF CANCER, 2014, 51 (03) : 384 - U266
  • [24] The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report
    Livingston, Caitlyn H.
    Harper, Benjamin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [25] Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer A Brief Report
    Shiao, Tsu-Hui
    Chang, Yih-Leong
    Yu, Chong-Jen
    Chang, Yeun-Chung
    Hsu, Ya-Chieh
    Chang, Shih-Han
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 195 - 198
  • [26] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [27] Highly Active Antitumor Therapy (HAATT) for Epidermal Growth Factor Receptor-Mutant Lung Cancer
    Chmielecki, Juliann
    Pao, William
    CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5371 - 5373
  • [28] Osimertinib: a breakthrough for the treatment of epidermal growth factor receptor mutant lung adenocarcinoma
    Karachaliou, Niki
    Barron Barron, Feliciano
    Viteri, Santiago
    Angel Molina, Miguel
    Rosell, Rafael
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S117 - S121
  • [29] Are EGFR (epidermal growth factor receptor) mutant lung cancers neurotropic and pleurotropic?
    Bulusu, V. R.
    Jessop, S.
    Jeffs, Y.
    Egan, A.
    Prasad, B.
    Poku, K. Adu
    Sa'D, A.
    Thomas, E.
    Azher, M.
    LUNG CANCER, 2015, 87 : S30 - S30
  • [30] Elevated serum epidermal growth factor receptor level is correlated with lymph node metastasis in lung cancer
    H. Sasaki
    H. Yukiue
    K. Mizuno
    A. Sekimura
    A. Konishi
    M. Yano
    M. Kaji
    M. Kiriyama
    I. Fukai
    Y. Yamakawa
    Y. Fujii
    International Journal of Clinical Oncology, 2003, 8 (2) : 0079 - 0082